Redcare Pharmacy NV (RDC.DE)

EUR 139.9

(-3.38%)

Revenue Summary of Redcare Pharmacy NV

Redcare Pharmacy NV's latest annual revenue in 2023 was 1.79 Billion EUR , up 49.35% from previous year.
Redcare Pharmacy NV's latest quarterly revenue in 2024 Q1 was 560.21 Million EUR , up 5.44% from previous quarter.
Redcare Pharmacy NV reported a annual revenue of 1.2 Billion EUR in annual revenue 2022, up 13.58% from previous year.
Redcare Pharmacy NV reported a annual revenue of 1.06 Billion EUR in annual revenue 2021, up 9.53% from previous year.
Redcare Pharmacy NV reported a quarterly revenue of 560.67 Million EUR for 2024 Q2, up 0.08% from previous quarter.
Redcare Pharmacy NV reported a quarterly revenue of 372.05 Million EUR for 2023 Q1, up 13.49% from previous quarter.

Annual Revenue Chart of Redcare Pharmacy NV (2023 - 2013)

Historical Annual Revenue of Redcare Pharmacy NV (2023 - 2013)

Year	Revenue	Revenue Growth
2023	1.79 Billion EUR	49.35%
2022	1.2 Billion EUR	13.58%
2021	1.06 Billion EUR	9.53%
2020	968.06 Million EUR	38.1%
2019	701.01 Million EUR	29.89%
2018	539.71 Million EUR	90.04%
2017	283.99 Million EUR	60.09%
2016	177.39 Million EUR	41.26%
2015	125.57 Million EUR	48.31%
2014	84.67 Million EUR	53.13%
2013	55.29 Million EUR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	560.21 Million EUR	5.44%
2024 Q2	560.67 Million EUR	0.08%
2023 Q1	372.05 Million EUR	13.49%
2023 Q3	475.5 Million EUR	13.24%
2023 Q2	419.88 Million EUR	12.86%
2023 Q4	531.31 Million EUR	11.74%
2023 FY	1.79 Billion EUR	49.35%
2022 Q3	284.51 Million EUR	-0.94%
2022 Q4	327.83 Million EUR	15.22%
2022 FY	1.2 Billion EUR	13.58%
2022 Q1	304.78 Million EUR	5.82%
2022 Q2	287.22 Million EUR	-5.76%
2021 Q1	284.05 Million EUR	7.3%
2021 Q2	250.38 Million EUR	-11.85%
2021 Q3	237.85 Million EUR	-5.01%
2021 FY	1.06 Billion EUR	9.53%
2021 Q4	288.02 Million EUR	21.09%
2020 Q3	238.68 Million EUR	2.58%
2020 FY	968.06 Million EUR	38.1%
2020 Q4	264.71 Million EUR	10.91%
2020 Q2	232.67 Million EUR	0.3%
2020 Q1	231.98 Million EUR	20.92%
2019 Q2	163.63 Million EUR	-6.31%
2019 FY	701.01 Million EUR	29.89%
2019 Q1	174.64 Million EUR	15.48%
2019 Q4	191.85 Million EUR	12.28%
2019 Q3	170.87 Million EUR	4.43%
2018 Q4	151.23 Million EUR	15.22%
2018 FY	539.71 Million EUR	90.04%
2018 Q1	130.66 Million EUR	40.76%
2018 Q2	126.56 Million EUR	-3.14%
2018 Q3	131.25 Million EUR	3.7%
2017 Q1	63.77 Million EUR	21.01%
2017 Q2	62.92 Million EUR	-1.33%
2017 Q4	92.82 Million EUR	44.01%
2017 Q3	64.45 Million EUR	2.43%
2017 FY	283.99 Million EUR	60.09%
2016 Q4	52.7 Million EUR	23.93%
2016 Q3	42.52 Million EUR	3.34%
2016 Q2	41.15 Million EUR	0.34%
2016 Q1	41.01 Million EUR	18.75%
2016 FY	177.39 Million EUR	41.26%
2015 Q1	30.26 Million EUR	0.0%
2015 FY	125.57 Million EUR	48.31%
2015 Q2	30.26 Million EUR	0.0%
2015 Q4	34.53 Million EUR	13.18%
2015 Q3	30.51 Million EUR	0.82%
2014 FY	84.67 Million EUR	53.13%
2013 FY	55.29 Million EUR	0.0%

Peer Revenue Comparison of Redcare Pharmacy NV

Name	Revenue	Revenue Difference
Newron Pharmaceuticals S.p.A.	9.05 Million EUR	-19760.417%